Cartesian Therapeutics, Inc. (RNAC)

CIK 1453687 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Cartesian Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Aug 13, 2026SCHEDULE 13G0000312069-26-000206
Aug 6, 20268-K0001453687-26-000100
Aug 6, 202610-Q0001453687-26-000101
Jul 22, 2026SCHEDULE 13G/A0000019617-26-000272
Jun 17, 20268-K0001453687-26-000090
Jun 9, 20261440001950047-26-005808
Jun 9, 20268-K0001140361-26-024556
Jun 2, 20261440001950047-26-005471
May 26, 20268-K0001453687-26-000087
May 6, 2026SCHEDULE 13G/A0000315066-26-001134
Apr 30, 20268-K0001453687-26-000081
Apr 30, 202610-Q0001453687-26-000082
Apr 30, 2026S-80001453687-26-000084
Apr 28, 2026DEF 14A0001453687-26-000072
Apr 28, 2026DEFA14A0001453687-26-000071
Apr 6, 202640002064832-26-000149
Apr 6, 202640002064832-26-000148
Apr 2, 2026SCHEDULE 13D/A0001193125-26-140633
Mar 30, 20268-K0001453687-26-000068
Mar 13, 202640001453687-26-000066
Mar 13, 2026SCHEDULE 13G0001642575-26-000003
Mar 9, 20268-K0001453687-26-000063
Mar 9, 202610-K0001453687-26-000064
Feb 5, 2026SCHEDULE 13G/A0000315066-26-000393
Jan 13, 20261440001950047-26-000366